Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer: results from the VICTOR trial.
McGregor MJ. et al, (2015), Anticancer res, 35, 1641 - 1645
PTEN loss in the continuum of common cancers, rare syndromes and mouse models.
Hollander MC. et al, (2011), Nat rev cancer, 11, 289 - 301
What is the role and impact of molecular markers on treatment decisions for colorectal cancer in the adjuvant setting?
Al-Salama HM. et al, (2009), Discov med, 8, 104 - 107
Smoking cessation, weight gain, and DRD4 −521 genotype
Munafò MR. et al, (2006), American journal of medical genetics part b: neuropsychiatric genetics, 141B, 398 - 402
Association of the dopamine-β-hydroxylase gene with nicotine dependence: No evidence for mediation by personality
Zetteler JI. et al, (2005), Personality and individual differences, 39, 1113 - 1122
Association between the serotonin transporter gene and alcohol consumption in social drinkers
Munafò MR. et al, (2005), American journal of medical genetics - neuropsychiatric genetics, 135 B, 10 - 14
Association of serotonin transporter gene polymorphism with nicotine dependence: no evidence for an interaction with trait neuroticism
Munafò MR. et al, (2005), Personality and individual differences, 38, 843 - 850
Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.
Yudkin P. et al, (2004), Bmj, 328, 989 - 990
The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population.
Johnstone EC. et al, (2004), Addict biol, 9, 221 - 226
Zyban for smoking cessation in a general practice setting: the response to an invitation to make a quit attempt.
Johnstone E. et al, (2004), Addict biol, 9, 227 - 232
Pharmacogenomics of Tobacco Addiction
Johnstone E. et al, (2003), Pharmacogenomics: The Search for Individualized Therapies, 443 - 460